NeoPhotonics Corporation (NPTN) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:NPTN • US64051T1007

16.01 USD
+0.01 (+0.06%)
At close: Aug 2, 2022
16.01 USD
0 (0%)
After Hours: 8/2/2022, 8:24:07 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to NPTN. NPTN was compared to 113 industry peers in the Semiconductors & Semiconductor Equipment industry. NPTN has a bad profitability rating. Also its financial health evaluation is rather negative. NPTN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year NPTN has reported negative net income.
NPTN Yearly Net Income VS EBIT VS OCF VS FCFNPTN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 0 20M -20M 40M -40M -60M -80M

1.2 Ratios

Industry RankSector Rank
ROA -10.28%
ROE N/A
ROIC -8.46%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NPTN Yearly ROA, ROE, ROICNPTN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 -5 -10 -15 -20 -25

1.3 Margins

Industry RankSector Rank
OM -7.62%
PM (TTM) -10.46%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NPTN Yearly Profit, Operating, Gross MarginsNPTN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 10 -10 20

2

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NPTN is destroying value.
  • NPTN has more shares outstanding than it did 1 year ago.
  • The debt/assets ratio for NPTN is higher compared to a year ago.
NPTN Yearly Shares OutstandingNPTN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 10M 20M 30M 40M 50M
NPTN Yearly Total Debt VS Total AssetsNPTN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 100M 200M 300M 400M

2.2 Solvency

  • An Altman-Z score of 2.22 indicates that NPTN is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • A Debt/Equity ratio of 0.36 indicates that NPTN is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Altman-Z 2.22
ROIC/WACC-0.84
WACC10.11%
NPTN Yearly LT Debt VS Equity VS FCFNPTN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 100M 200M

2.3 Liquidity

  • NPTN has a Current Ratio of 2.57. This indicates that NPTN is financially healthy and has no problem in meeting its short term obligations.
  • NPTN has a Quick Ratio of 1.95. This is a normal value and indicates that NPTN is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 2.57
Quick Ratio 1.95
NPTN Yearly Current Assets VS Current LiabilitesNPTN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M 250M

4

3. Growth

3.1 Past

  • NPTN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1050.00%.
  • NPTN shows a decrease in Revenue. In the last year, the revenue decreased by -4.80%.
  • The Revenue has been decreasing by -6.74% on average over the past years.
EPS 1Y (TTM)-1050%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%126.67%
Revenue 1Y (TTM)-4.8%
Revenue growth 3Y-3.45%
Revenue growth 5Y-6.74%
Sales Q2Q%46.58%

3.2 Future

  • Based on estimates for the next years, NPTN will show a very strong growth in Earnings Per Share. The EPS will grow by 72.02% on average per year.
  • NPTN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 20.89% yearly.
EPS Next Y169.52%
EPS Next 2Y97.65%
EPS Next 3Y77.09%
EPS Next 5Y72.02%
Revenue Next Year26.78%
Revenue Next 2Y21.43%
Revenue Next 3Y20.67%
Revenue Next 5Y20.89%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NPTN Yearly Revenue VS EstimatesNPTN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
NPTN Yearly EPS VS EstimatesNPTN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1 2

2

4. Valuation

4.1 Price/Earnings Ratio

  • NPTN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Based on the Price/Forward Earnings ratio of 20.00, the valuation of NPTN can be described as rather expensive.
  • The average S&P500 Price/Forward Earnings ratio is at 27.77. NPTN is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 20
NPTN Price Earnings VS Forward Price EarningsNPTN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -266.15
NPTN Per share dataNPTN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • NPTN's earnings are expected to grow with 77.09% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y97.65%
EPS Next 3Y77.09%

0

5. Dividend

5.1 Amount

  • No dividends for NPTN!.
Industry RankSector Rank
Dividend Yield N/A

NeoPhotonics Corporation

NYSE:NPTN (8/2/2022, 8:24:07 PM)

After market: 16.01 0 (0%)

16.01

+0.01 (+0.06%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-05
Earnings (Next)11-02
Inst Owners1.01%
Inst Owner Change0%
Ins Owners18.64%
Ins Owner Change0%
Market Cap859.58M
Revenue(TTM)318.63M
Net Income(TTM)-33.33M
Analysts74.55
Price Target15.81 (-1.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 20
P/S 2.7
P/FCF N/A
P/OCF N/A
P/B 5.67
P/tB N/A
EV/EBITDA -266.15
EPS(TTM)-0.23
EYN/A
EPS(NY)0.8
Fwd EY5%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS5.93
BVpS2.82
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -10.28%
ROE N/A
ROCE N/A
ROIC -8.46%
ROICexc N/A
ROICexgc -8.53%
OM -7.62%
PM (TTM) -10.46%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.57
Quick Ratio 1.95
Altman-Z 2.22
F-Score1
WACC10.11%
ROIC/WACC-0.84
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1050%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%126.67%
EPS Next Y169.52%
EPS Next 2Y97.65%
EPS Next 3Y77.09%
EPS Next 5Y72.02%
Revenue 1Y (TTM)-4.8%
Revenue growth 3Y-3.45%
Revenue growth 5Y-6.74%
Sales Q2Q%46.58%
Revenue Next Year26.78%
Revenue Next 2Y21.43%
Revenue Next 3Y20.67%
Revenue Next 5Y20.89%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

NeoPhotonics Corporation / NPTN FAQ

What is the fundamental rating for NPTN stock?

ChartMill assigns a fundamental rating of 2 / 10 to NPTN.


What is the valuation status for NPTN stock?

ChartMill assigns a valuation rating of 3 / 10 to NeoPhotonics Corporation (NPTN). This can be considered as Overvalued.


How profitable is NeoPhotonics Corporation (NPTN) stock?

NeoPhotonics Corporation (NPTN) has a profitability rating of 0 / 10.